• home link.
  • steps to recovery link.
  • healthy living link.
  • daily living link.
  • sci research link.
  • rehab adventures link.
  • spinalpedia link.

Top Scientists

Click Here — Learn more about top scientists and watch thousands of SCI videos on SPINALpedia!

Click Here — Check out our Spinal Cord Injury Research Pinterest board

Click Here — Check out our Spinal Cord Injury Health Pinterest board

Click a Scientist

Listed below are different scientists (not listed in any particular order)

Dr. Hans Keirstead Ph.D. Dr. Wise Young M.D., Ph.D.
Dr. Juanita J. Anders Ph.D. Dr. Huang Hongyun
Dr. W. Dalton Dietrich III Ph.D. Dr. Stephen Davies Ph.D.
Dr. Geoff Raisman Dr. John Gearhart Ph.D.
Dr. John McDonald  M.D., Ph.D.
Dr. Hans S. Keirstead is an Associate Professor at the Reeve-Irvine Research Center, and Co-Director of the Stem Cell Research Center at the University of California, Irvine.The Canadian-born neuroscientist received his PhD from the University of British Columbia in Vancouver, Canada. His PhD thesis concerned his invention of a novel method for regenerating damaged spinal cords, and formed the basis of several worldwide patents as well as the formation of a company in 1999.

This work constituted the first demonstration of functional regeneration of the injured adult spinal cord, and for his achievements he received the Cameron Award for the outstanding PhD thesis in Canada. Dr. Keirstead then moved to Cambridge England, where he conducted 4 years of Post-Doctoral studies at the University of Cambridge furthering his studies of spinal cord injury and beginning studies of multiple sclerosis.

He was awarded Canadian and British Fellowships to support this work. He received the distinct honor of election to two senior academic posts, Fellow of the Governing Body of Downing College, and Senate Member of the University of Cambridge, and was the youngest member to be elected to those positions.

In 2000, Dr. Keirstead joined the Reeve-Irvine Research Center at the University of California at Irvine. The Reeve-Irvine Research Center, founded by the late Christopher Reeve and philanthropist Joan Irvine, is a leading center for spinal cord injury research.

Dr. Keirstead directs a large team investigating the cellular biology and treatment of spinal cord trauma, research that also has significance for multiple sclerosis and other diseases of the nervous system. In order to bring his treatments to clinical trials, he has founded or partnered with several biotechnology companies to fund and conduct pre-clinical and clinical development

Dr. Keirstead was recently awarded the Distinguished Assistant Professor of UCI Award, the UCI Academic Senate’s highest honor, and was thereafter promoted to Associate Professor with tenure.In 2005, he was awarded the UCI Innovation Award for innovative research leading to corporate and clinical development.

Dr. Keirstead has testified at Federal and California Senate Hearings on several occasions regarding the potential of stem cells, is an avid scientific correspondent for public education, is on the EditorialBoard of 4 major journals, and was an advisor to the CA government on stem cell policy.

He was also a Scientific Advisory Committee Member of the California Stem Cell Initiative that authored Proposition 71, and maintains working relationships with several stem cell companies, venture capital groups, and government economic development offices in the United States, Sweden and Norway.

Dr. Keirstead is also Vice Chancellor of Academic Development at UDECOM (University of Community Development, in French) situated in Guinea, Africa.

UDECOM grants Bachelors and PhD degrees for community development in rural Africa. Dr. Keirstead leads several efforts to develop the university and improve the quality of life for those in the surrounding communities.

Department of NeurosurgeryChaoyang HospitalCapital University of Medical Sciences Beijing, China

Chair, Department of Cell Biology and Neuroscience
Scientific DirectorThe Miami Project to Cure Paralysis
Darwin Prockop, M.D., Ph.D.
Professor of Biochemistry
Director, Center for Gene Therapy,
Tulane University Health Sciences Center
Director Purdue University Center
National Institue for Medical ResearchHead of Division Neurobiology
Institute for Cell Engineering
Johns Hopkins Medicine
Visiting Associate Professor University of Colorodo Department of Neurology
graduated from the University of Illinois, Champaign Urbana in 1985 with Bachelor’s of Science degree, magna cum laude, in Neuroscience. From there he matriculated at the University of Michigan, Ann Arbor, where he began a combined M.D./Ph.D. program in the Medical Scientists Training Program (MSTP) that he completed in 1992.While pursuing his advanced degrees, Dr. McDonald completed a fellowship in Neurology at the Johns Hopkins University School of Medicine and served as visiting scientist at Eli Lilly and Co in Indianapolis, IN. After receiving his M.D. and his doctorate, Dr. McDonald completed an internship in preliminary medicine at St. Joseph Mercy Hospital in Ann Arbor, MI.

From 1993-1996, he completed his postgraduate training in adult Neurology at St. Louis’ Barnes Hospital and Washington University School of Medicine. Following his residency, Dr. McDonald joined the Washington University faculty in the Department of Neurology as an instructor in 1997, promoted to assistant professor of Neurology at Washington University School of Medicine.

He also held co-assistant professorships in the School’s Departments of Neurological Surgery and Anatomy and Neurobiology.In 1998, Dr. McDonald was named Medical Director of the Spinal Cord Neurorehabilitative Unit at Barnes-Jewish Hospital in St. Louis and Section Head of Spinal Cord Injury Program at Washington University.

There he spearheaded development of what is now a leading spinal cord injury neuralrestoration program. It was there that he developed the “activity-based restoration” (ABR) therapies designed to help patients with long-term spinal cord injuries recover sensation, movement and independence; the therapy approached publically acknowledged as producing the substantial and delayed recovery of actor/activist Christopher Reeve.

Dr. McDonald joined Kennedy Kennedy Krieger Institute in 2004 in order to launch a brand-new spinal cord rehabilitation and research program with a focus on pediatric paralysis, a program that will become the only of its kind in the world.

Dr. McDonald also holds a primary appointment as Associate Professor in the Department of Neurology at Johns Hopkins University School of Medicine with co-appointments in Physical Medicine and Rehabilitation and Neuroscience departments.

Dr. McDonald sits on the advisory boards of two companies, Restorative Therapies, Inc. of Baltimore, MD and BioAxone of Montreal, Canada. He is the present Chairman of the Spinal Cord Injury Research Program Advisory Board at the University of Missouri, Columbia and holds positions on the New York State SCI Research board, and the Philadelphia Shriner’s Hospital Medical Advisory Board.

Recent professional honors include being named Medical Director of the Year by insurer HealthSouth, receiving the SCI Research Inspiration Award from the Sam Schmidt Foundation and receiving the Reeve Research for Freedom Award from Gateway to a Cure.

Research Summary:  Dr. McDonald’s research interests focus on the development of interventions to reduce spinal cord injury, promote remyelination, enhance regeneration and encourage recovery of function.

In addition, Dr. McDonald is interested in studying the biology of embryonic stem cells, neural progenitor cells, mechanisms of oligodendrocyte death and glutamate excitotoxicity, mechanisms regulating myelination and the ontogeny of excitatory amino acid and related neurotransmitter pathways in the brain and their relationship to neurological disease.

Dr. McDonald also actively leads industry multi-center clinical trials in spinal cord injury repair, having completed 6 trials to date including the first human stem cell transplantation study with the company Diacrin.

In addition to the completion of an ongoing project examining the efficacy of activity-based restoration in 60 adult patients with spinal cord injuries, Dr. McDonald and his team at the International Center for Spinal Cord Injury will soon launch a large prospective multi-center trial evaluating the efficacy of these therapies in pediatric patients in collaboration with the Philadephia Shriner’s Hospital.

Dr. McDonald’s research is increasingly focusing on approaches to regeneration and restoration of function in spinal cord injury and other disorders of paralysis using activity-base therapies. Such focus includes other regenerative approaches that have the potential of being translated into human therapies in the near-term.

Click Your Level of Injury

Medical Disclaimer: The Determined2heal Foundation offers educational and health related information relevant to persons with spinal cord injuries, their families, and others of interest. The information contained herein on this site is neither intended nor implied to be a substitute for professional medical advice. Always seek advice from your physician or other qualified health professionals before implementing any new regiment concerning your individual health. Always seek the advice of your physician prior to starting or changing any medical or health treatment.

Links Disclaimer: The Determined2heal Foundation manages and updates information along with links to web sites around the world that contain spinal cord injury products and educational information. The links provided are not managed by the Determined2heal Foundation, and therefore, Determined2heal is not responsible for their content.

Copyright: All written information produced by the Determined2heal Foundation that is contained on this web site is protected under copyright laws. It is prohibited to copy in part or whole any written information from this web site to be posted on other web sites. Information that appears on this site is held by the publisher/developer of the material. Contact individual publisher/developer for permission to use their information.